ZIMV (ZimVie) YoY EBITDA Growth: 83.81% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZIMV ZimVie Inc ZIMV
14 GF Score
Price $18.99
View Full Analysis

What is ZimVie YoY EBITDA Growth?

ZimVie ZIMV 14 YoY EBITDA Growth is 83.81% as of Jun. 2025. GuruFocus rates ZIMV with a GF Score™ of 14/100.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. ZimVie's YoY EBITDA Growth for the quarter that ended in Jun. 2025 was 83.81%.

ZimVie's EBITDA per Share for the three months ended in Jun. 2025 was $0.45.

ZimVie YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for ZimVie's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ZimVie YoY EBITDA Growth Chart

ZimVie Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial -180.65 133.11 175.91 13.44 -68.66

ZimVie Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -76.89 -63.73 -45.36 138.19 83.81
ZIMV
14GF Score
ZimVie Inc ZIMV
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ZimVie YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

ZimVie's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(1.079-3.443)/ | 3.443 |
=-68.66 %

ZimVie's YoY EBITDA Growth for the quarter that ended in Jun. 2025 is calculated as:

YoY EBITDA Growth (Q: Jun. 2025 )
=(EBITDA per Share (Q: Jun. 2025 )-EBITDA per Share (Q: Jun. 2024 )) / | EBITDA per Share (Q: Jun. 2024 )) |
=(0.454-0.247)/ | 0.247 |
=83.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 83.81% mean?
ZimVie (ZIMV) has a YoY EBITDA Growth of 83.81% as of Jun. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for ZimVie and its competitors.
Is ZimVie's YoY EBITDA Growth too high?
ZimVie's current YoY EBITDA Growth is 83.81%. Overall, ZimVie has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does ZimVie's YoY EBITDA Growth compare to CTKB and LAB?
ZimVie's YoY EBITDA Growth of 83.81% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for ZimVie and its competitors. ZimVie's current YoY EBITDA Growth is 83.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ZimVie stock overvalued right now?
ZimVie (ZIMV) has a current YoY EBITDA Growth of 83.81%. The current YoY EBITDA Growth is 83.81%. ZimVie's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For ZimVie (ZIMV), the current YoY EBITDA Growth is 83.81% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ZimVie Business Description

Address 4555 Riverside Drive, Palm Beach Gardens, Florida, DE, USA, 33410
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
14GF Score

Get the complete analysis for ZIMV

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.99
Price